Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs

• Mark J. Siedner ,

  * E-mail: msiedner@partners.org

  Affiliation Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Alexander Lankowski,

  Affiliations Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Mbarara University of Science and Technology, Mbarara, Uganda

  ⨯
• Jessica E. Haberer,

  Affiliation Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Annet Kembabazi,

  Affiliation Mbarara University of Science and Technology, Mbarara, Uganda

  ⨯
• Nneka Emenyonu,

  Affiliation Mbarara University of Science and Technology, Mbarara, Uganda

  ⨯
• Alexander C. Tsai,

  Affiliation Robert Wood Johnson Health and Society Scholars Program, Harvard University, Boston, Massachusetts, United States of America

  ⨯
• Conrad Muzoora,

  Affiliation Mbarara University of Science and Technology, Mbarara, Uganda

  ⨯
• Elvin Geng,

  Affiliation University of California, San Francisco, California, United States of America

  ⨯
• Jeffrey N. Martin,

  Affiliation University of California, San Francisco, California, United States of America

  ⨯
• David R. Bangsberg

  Affiliations Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Robert Wood Johnson Health and Society Scholars Program, Harvard University, Boston, Massachusetts, United States of America, Massahusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America, Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯